Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Dear dkNET Community,
dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.
dkNET Updates:
International Institute for the Advancement of Medicine (RRID:SCR_016172) is a biomaterial supplier that links organ and tissue donors with the scientific community. After securing the appropriate consent, IIAM provides non-transplantable organs and tissues to researchers for use in medical discovery and education
Datasets2Tools (RRID:SCR_016174) is a database for the discovery and evaluation of biomedical digital objects. It includes a wide variety of enrichment analyses, gene interaction networks, interactive data visualizations, datasets, and computational tools.
Direct Infusion Metabolite Database (RRID:SCR_016188) is a database of metabolite structures and annotations. The sources are from multiple existing metabolic and chemical databases such as HMDB, PubChem, CHEBI, BioCyc, and KEGG.
Events in May, 2018
May 1, 2018
Abstract Submission Deadline: ObesityWeek
The Obesity Society’s Annual Scientific Meeting has grown to be one of the world’s largest gatherings of obesity professionals at all stages of their careers, including leading obesity scientists presenting cutting-edge research. The meeting brings together the leading players in the field of obesity from world-renowned speakers, researchers and clinicians to educators, advocates, policymakers and practitioners. And, it provides essential educational and networking opportunities and is a forum for increasing knowledge, stimulating research, and promoting better treatment for those affected by this disease.
Location: Nashville, TN, USA
More information: http://www.obesity.org/meetings/obesity-week
May 4, 2018
Abstract submission deadline: 2nd International Symposium on Lipid Oxidation and Antioxidants
This meeting will be a great opportunity to discuss theoretical aspects of lipid oxidation as well as state-of-the-ar
More information: https://veranstaltungen.gdch.de/tms/frontend/index.cfm?l=7710&sp_id=2
May 4, 2018
Workshop Application Deadline: 6th Annual Workshop on Metabolomics at University of Alabama at Birmingham The themes in this sixth year of the workshop are:
Location: Birmingham, AL, USA
More information: https://www.uab.edu/proteomics/metabolomics/workshop/workshop_july_2018.php#tab_tab1
May 22-23, 2018
Workshop Registration Deadline: Obesity and Fat Metabolism in HIV Infected Individuals
Meeting Objectives:
Location: Rockville, MD, USA
More information: https://www.niddk.nih.gov/news/meetings-workshops/2018/obesity-and-fat-metabolism-in-hiv-infected-individuals
May 23, 2018
Abstract Submission Deadline: 88th Annual Meeting of the American Thyroid Association
Join over 1,300 THYROID clinicians, investigators and healthcare professionals from around the world to hear the latest clinical and basic science research on thyroid disease at the 88th Annual Meeting of the American Thyroid Association (ATA) on October 3-7, 2018. The ATA Program Committee led by Gregory Randolph and Mabel Ryder will offer a program consistent with the excellence for which the ATA is known. The ATA meeting is designed for the community of endocrinologist
Location: Washington DC, USA
More information: https://www.thyroid.org/88th-annual-meeting-ata/
May 29, 2018
Workshop Registration Deadline: Beyond Transcriptomics: Understanding Erythrocyte Maturation
Prior to nuclear extrusion from pronormoblasts, critical pathways are developed and continue functioning to ensure optimal erythrocyte function. Knowledge about individual gene products does not necessarily inform us about pathways/proces
Location: Bethesda, MD, USA
More information: https://www.niddk.nih.gov/news/meetings-workshops/2018/beyond-transcriptomics-understanding-erythrocyte-maturation
May 31 - June 1, 2018
NIDDK Workshop: Congenital Anomalies of External Genitalia Workshop
The Congenital Anomalies of External Genitalia Workshop will be held on May 31st and June 1st, 2018 at the AUA Headquarters in Linthicum, MD. This two-day meeting will bring together researchers from a range of disciplines, including pediatric urology, developmental biology, genetics & genomics, computational biology, endocrinology, and epidemiology, with the goal of advancing basic and clinical research in hypospadias and related disorders of external genital development. Presentations and roundtable discussions of current research strategies will aim to identify key knowledge gaps and missed opportunities, and to develop potential investigative solutions that will address deficiencies in the field. Basic and clinical researchers interested in the causes of hypospadias and related congenital anomalies of external genitalia are encouraged to attend.
Location: Linthicum Heights, MD, USA
More information: https://www.niddk.nih.gov/news/meetings-workshops/2018/congenital-anomalies-external-genitalia-workshop
May 31, 2018
Abstract Submission Deadline: Kidney Week
Join ASN and more than 13,000 other kidney professionals from across the globe at Kidney Week 2018 in San Diego, CA on Oct. 23-28, 2018. The world's premier nephrology meeting, Kidney Week provides participants exciting and challenging opportunities to exchange knowledge, learn the latest scientific and medical advances, and listen to engaging and provocative discussions with leading experts in the field.
Location: San Diego, CA, USA
More information: https://www.asn-online.org/education/kidneyweek/
Funding opportunities information and deadlines in May, 2018
May. 3, 2018
Funding Opportunity Application Due Date: Michigan Metabolomic And Obesity Center(MMOC) And Michigan Nutrition And Obesity Research Center (MNORC) Pilot And Feasibility Program
The purpose of the MNORC Pilot /Feasibility (P/F) Grant Program is to promote research on the biological and behavioral determinants of obesity, and to develop interventions to reduce obesity and its disease sequelae using basic, clinical, or population approaches. The P/F program’s aim is to enable both new and established University of Michigan investigators to generate sufficient preliminary information for a successful application for major research funding from NIH or other national granting agencies. Grant proposals may be in areas of basic biomedical research or in clinical, epidemiological
More information: https://umms.infoready4.com/#competitionDetail/1770146
May. 4, 2018
Funding Opportunity Application Deadline: Nutrition Obesity Research Center, University Of Alabama At Birmingham Pilot And Feasibility Program
Pilot/Feasibili
More information: http://www.norc.uab.edu/pilot/opportunities
May 4, 2018
Funding Opportunity Application Due Date: 2018 (Re)Building A Kidney Consortium Partnership Program
The RBK Partnership Project Program (PPP) invites investigators to submit applications that, if successful, will become part of the RBK (RFA-DK-14-010 & RFA-DK-14-009). The PPP aims to support the goals of the RBK through solicitation of additional projects and/or expertise in specific subject areas. Awardees of the PPP become full members of the RBK. Applications of 5 pages requesting up to $150,000 total cost per year for two years are due May 4, 2018. Current subject areas of interest are LIMITED to Physiologic Function and Re
May 8, 2018
Information Webinar for Applicants to “Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional)”
Webinar to assist applicants to Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional).May 10, 2018
HIRN RFA Funding Opportunity Application Due Date: Discovery of Early Type 1 Diabetes Disease Biomarkers in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) requests applications to explore human pancreatic tissues for the discovery of early biomarkers of T1D pathogenesis, the description of specific signaling or processing pathways that may contribute to the asymptomatic phase of T1D, the development of clinical diagnostic tools for the detection and staging of early T1D in at-risk or recently-diagnosed individuals, and/or the identification of therapeutic targets for the development of preventative or early treatment strategies. Successful applicants will join the Consortium on Beta Cell Death and Survival (CBDS), whose mission is to better define and detect the mechanisms of beta cell stress and destruction central to the development of T1D in humans, with the long-term goal of detecting beta cell destruction and protecting the residual beta cell mass in T1D patients as early as possible in the disease process, and of preventing the progression to autoimmunity. The CBDS is part of a collaborative research framework, the Human Islet Research Network (HIRN, https://hirnetwork.org), whose overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This FOA will only support studies with a primary focus on increasing our understanding of human disease biology (as opposed to rodent or other animal models). This FOA will not accept applications proposing a clinical trial.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-021.html
May 10, 2018
HIRN RFA Funding Opportunity Application Due Date: High-Resolution Exploration of the Human Islet Tissue Environment [HIRN Human Pancreas Analysis Consortium (HPAC)] (U01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) invites cooperative agreement applications that will contribute to a higher resolution understanding of the physical and functional organization of the human islet tissue environment by describing the composition (cellular and molecular) and function of important components of the pancreatic islet and peri-islet tissue architecture, the cell-cell relationships and means of communications used by cell types and cell subtypes within the pancreatic tissue ecosystem, and/or the contribution of adjacent (including acinar, ductal, lymphatic) and neighboring (intestinal, mesenteric and adipose) tissues to islet cell function and dysfunction. Successful projects will integrate the Human Pancreas Analysis Consortium (HPAC), that will consist of the research teams funded in response to this FOA with the Human Pancreas Analysis Program (HPAP), a resource-generation program that was funded in 2016 in response to RFA-DK-15-027. HPAC will become the fifth consortium of the Human Islet Research Network (HIRN, https://hirnetwork.org/ ). HIRN's overall mission is to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional beta cell mass in humans. This FOA will only support studies with a primary focus on increasing our understanding of human tissue structure and function, and human disease biology (as opposed to rodent or other animal models). This FOA will not accept applications proposing a clinical trial.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-022.html
May 10, 2018
NIDDK Funding Opportunity Application Due Date: Development and Integration of Novel Components for Open and Closed Loop Hormone Replacement Platforms for T1D Therapy (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/organizations proposing original research addressing barriers that limit progress toward effective open- and closed-loop glucose control systems. Proposed research should tackle important obstacles at the level of sensing, hormone formulation and delivery, self-management decision support systems, and/or design of automated controllers/algorithms able to manage an integrated platform. This research may contribute to development of affordable and user friendly technologies to improve glucose control in patients with type 1 diabetes.
May 10, 2018
NIDDK Funding Opportunity Application Due Date: Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/orMay 10, 2018
NIDDK Funding Opportunity Application Due Date: Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)
Type 1 diabetes (T1D) results in part from the autoimmune-mediMay 11, 2018
Funding Opportunities Application Deadline: Application Deadline: Chicago Center For Diabetes Translation Research Pilot And Feasibility Grants Program
Chicago Center for Diabetes Translation Research Pilot and Feasibility Grants Program aimed at: 1) Attracting more junior investigators of the faculty into the area of type II diabetes-relateMay 11, 2018
Information Webinar for Applicants to “Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional)”
Webinar to assist applicants to Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional).May 31, 2018
Funding Opportunity Application Due Date: Georgia Center For Diabetes Translation Research: Pilot & Feasibility Pilot Award Program
Emory University, in partnership with Georgia Tech and Morehouse School of Medicine, has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to establish the Georgia Center for Diabetes Translation Research (Georgia CDTR). The mission of the center is to facilitate and grow diabetes translation research at Emory, its partner institutions, and regionally. In alignment with this mission, this Request for Pilot and Feasibility Applications is a solicitation for pilot proposals that focus on Type II translation research in diabetes care and prevention. Type II (T2) translation is defined as research focused on translating interventions/a